BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Phase III (World)
Boehringer Ingelheim Corporation Rethinks Hepatitis Business, Braces For A Rough 2014 4/17/2014  More...
AbbVie (ABBV)'s Experimental Hepatitis C Regimen Associated With High Cure Rates In Late-Stage Studies 4/15/2014  More...
BioAlliance Pharma Announces A New Positive DSMB Recommendation To Continue Its Phase 3 Clinical Trial With Livatag® In Primary Liver Cancer 4/14/2014  More...
BioAlliance Pharma Announces A New Positive DSMB Recommendation To Continue Its Phase III Clinical Trial With Livatag® In Primary Liver Cancer 4/14/2014  More...
Biogen Idec, Inc. (Massachusetts) (BIIB)'s Blood Disorder Drug Succeeds In Phase 3 Trial 4/10/2014  More...
Alkermes plc (ALKS) Pulls Off Phase 3 Win for Long-Lasting Schizophrenia Drug 4/9/2014  More...
GlaxoSmithKline (GSK) Halts Late-Stage Lung Cancer Vaccine Trial 4/3/2014  More...
Medivir AB (MVRBF) Release: Two Phase 3 Trials Evaluating Once-Daily Simeprevir And Sofosbuvir In Hepatitis C Infected Patients Have Been Initiated 4/2/2014  More...
Novartis AG (NVS) Closes Heart Drug Study Early After Strong Results 4/1/2014  More...
Novartis AG (NVS)'s Rare Lung Cancer Drug Ceritinib Shows Positive Response In Study 3/27/2014  More...
Swedish Orphan Biovitrum Release: Kiobrina Pivotal Phase 3 Study Did Not Meet Primary Endpoint 3/26/2014  More...
CogState Ltd (CGS.AX)'s Technology Chosen For Major Phase 3 Trial Of Alzheimer's Disease Drug 3/25/2014  More...
Novo Nordisk A/S (NVO) Reports Positive Results From First Phase 3 Trial With N8-GP, A Long-Acting Factor VIII For Treatment Of Haemophilia A 3/19/2014  More...
Alcobra (ADHD) Announces Enrollment Of First Patient In Phase 3 Clinical Trial For MDX In Adult ADHD 3/18/2014  More...
GlaxoSmithKline (GSK), Theravance, Inc. (THRX) Touts Positive Results From Three COPD Phase 3 Studies 3/17/2014  More...
Medivir AB (MVRBF) Release: New Phase 3 Data From Once-Daily Simeprevir Presented At The Conference Of The Asian Pacific Association For The Study Of The Liver (APASL) 3/17/2014  More...
GlaxoSmithKline (GSK) Touts Positive Asthma Drug Results From Two Phase 3 Studies 3/14/2014  More...
CrystalGenomics Announces Positive Results Of Phase 3 Trial Of Polmacoxib (CG100649) In Patients With Osteoarthritis 3/13/2014  More...
Novartis AG (NVS) Drug Jakavi® Gets Tagged As A Potential Blockbuster After Positive Late-Stage Study 3/10/2014  More...
RedHill Biopharma Ltd. (RDHL) Provides Update On RHB-102 Development And Intellectual Property 3/7/2014  More...
Genmab A/S (GEN.CO) Announces Phase 3 Study Of Daratumumab In Relapsed Or Refractory Multiple Myeloma 3/5/2014  More...
Actelion Ltd. (ALIOF.PK)'s Diarrhea Treatment Gets Fast-Track From The FDA 3/3/2014  More...
LFB S.A. Initiates Global Phase 3 Clinical Trial Of New Coagulation Factor Viia (Recombinant) In Patients With Hemophilia A And B 3/3/2014  More...
Shire plc Release:” New Phase 3 Data For Guanfacine Extended Release (GXR) To Be Presented At European Congress Of Psychiatry 2/27/2014  More...
Sinovac Biotech Ltd. (SVA)'s EV71 Vaccine Phase III Clinical Trial Results Published In The New England Journal of Medicine 2/27/2014  More...
Auris Medical AG Announces Enrollment Of First Patient In European Phase 3 Study Of AM-101 In Treatment Of Acute Peripheral Tinnitus 2/21/2014  More...
AB Science (AB.PA): Initiation Of A New Phase 3 Study With Masitinib In Prostate Cancer, Following Encouraging Survival Results Obtained In A Phase 2 Study 2/21/2014  More...
AB Science (AB.PA): Initiation Of A New Phase 3 Study With Masitinib In Prostate Cancer, Following Encouraging Survival Results Obtained In A Phase 2 Study 2/20/2014  More...
Active Biotech AB (BTPC) Release: Change In The Clinical Development Program For Laquinimod 2/19/2014  More...
GlaxoSmithKline (GSK) Finally Starts Much-Anticipated Phase 3 Study For Rare Disease 2/17/2014  More...
AstraZeneca PLC (AZN) Chases Demon Disease Cure, Potential To Be A Blockbuster Drug 2/17/2014  More...
Merck & Co., Inc. (MRK) Joins Race To Copy Sanofi (France) (SAN.PA)'s Lantus 2/12/2014  More...
Shire plc Scraps Vyvanse® For Depression After Failed Phase 3 Trials 2/7/2014  More...
Ipsen (IPN.PA) Says Phase 3 Prostate Cancer Drug Study Results Are Positive 2/7/2014  More...
GlaxoSmithKline (GSK) Talks Up Its Pipeline 2/6/2014  More...
Zealand Pharma  (ZEAL.CO) Informs That Sanofi (France) (SAN.PA) Has Announced Initiation Of The Lixilan Phase 3 Clinical Program For The Fixed-Ratio Combination Of Lantus® And Lyxumia® 2/6/2014  More...
Ipsen (IPN.PA) Announces Clinical Results Of Dysport® Next Generation (DNG) And Its Intent To File The First Ready-To-Use Liquid Toxin A In Europe And ROW1 2/5/2014  More...
Medivation, Inc. (MDVN) Prevails Again As Prostate Cancer Drug Impresses In Pre-Chemo Study 1/30/2014  More...
Otsuka Pharmaceutical Co., Ltd. And H. Lundbeck A/S (LUN.CO) To Present New Data On Brexpiprazole In Major Depression (MDD) At European Congress Of Psychiatry (EPA) 1/24/2014  More...
Roche (RHHBY)'s Schizophrenia Drug, Bitopertin, Misses Goal In Two Late-Stage Trials 1/22/2014  More...
ProSensa Holding N.V. (RNA) Reports Initial Findings From The Further Clinical Data Analyses Of Drisapersen For The Treatment Of Duchenne Muscular Dystrophy 1/16/2014  More...
Zealand Pharma  (ZEAL.CO) Announces Advance By Sanofi (France) (SAN.PA) Of Lixilan, The Single Injection Lyxumia®/Lantus® Combination Product, Towards Phase 3 Development And A Related Milestone Payment 1/15/2014  More...
ADImmune Corporation Plans To Sell Its Flu Vaccine In China This Year 1/7/2014  More...
Shield Therapeutics' ST10 Delivers Robust Results Meeting Both Primary And Secondary Endpoints In The Pivotal AEGIS Phase 3 Program For The Treatment Of Iron Deficiency Anemia In Inflammatory Bowel Disease 1/7/2014  More...
TauRx Therapeutics Expands Alzheimer's Clinical Trials In The United States 1/6/2014  More...
RedHill Biopharma Ltd. (RDHL) Provides Update On Pk Program In Support Of Ongoing Rhb-104 Phase 3 Crohn's Study 1/6/2014  More...
Takeda Pharmaceutical Co. Ltd. (TKPYY) Dealt A Huge Blow As Development Of Diabetes Drug Is Terminated 1/2/2014  More...
OphthaliX Inc.'s Dry Eye Drug CF101 Fails To Meet Goals In Phase 3 Study 12/31/2013  More...
Veloxis Pharmaceuticals A/S (VELO) Envarsus® Granted Orphan Drug Status By FDA For Kidney Transplant Rejection Prophylaxis 12/27/2013  More...
RedHill Biopharma Ltd. (RDHL) Reports Positive PK Results In Support Of Ongoing RHB-105 Phase 3 H. Pylori Study 12/23/2013  More...
ProSensa Holding N.V. (RNA) Comments On Drisapersen Program Update 12/20/2013  More...
Onconova Therapeutics Inc. (ONTX) Tanks As Study Of Lead Pancreatic Drug Fails Phase 3 Trial; Stock Down -18.68% At Market Close (Dec. 18, 2013) 12/19/2013  More...
Andromeda Biotech Announces First Patient Dosed In Extension Study To Its Phase 3 Clinical Trial DIA-AID 2 In Patients With Type 1 Diabetes 12/18/2013  More...
FINOX Biotech Announces First Patients Enrolled In Pivotal US Phase III (FIN3002) Study For Rfsh 12/17/2013  More...
RedHill Biopharma Ltd. (RDHL) Announces First Patients Dosed In Phase 3 Study Of RHB-105 For H. Pylori Infection 12/17/2013  More...
Ipsen (IPN.PA) Announces Positive Initial Results From The International Double-Blind Clinical Phase III Study of Dysport® In The Treatment Of Adults Suffering From Upper Limb Spasticity 12/17/2013  More...
Hepatitis C: Phase 3 Data Show Boehringer Ingelheim Corporation's Faldaprevir* Is Effective Even In Patients With Common Drug-Resistant Viral Variant 12/16/2013  More...
AstraZeneca PLC (AZN) Announces Top-Line Results From Phase 3 Monotherapy Study Of Lesinurad In Gout Patients 12/16/2013  More...
Kamada Ltd. (KMDA.TA) Announces Completion Of Pivotal Phase 2/3 Clinical Trial In Europe And Canada Of Inhaled AAT To Treat Alpha-1 Antitrypsin Deficiency 12/11/2013  More...
Novartis AG (NVS) Bone Marrow Cancer Drug Wows In Late-Stage Study 12/9/2013  More...
GlaxoSmithKline (GSK), Theravance, Inc. (THRX)'s Asthma Drug Improved Lung Function In Phase 3 Study 12/9/2013  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) And Swedish Orphan Biovitrum Release: New Phase 3 Data Confirm Long-Lasting Characteristics Of ALPROLIX™ And ELOCTATE™ Across Multiple Hemophilia Populations 12/9/2013  More...
Phase 3 Data Show Daiichi Sankyo, Inc. (4568.t)'s Once-Daily Edoxaban Lowered Incidence Of VTE Recurrence And Clinically Relevant Bleeding Compared To Warfarin In A Large Subgroup Of Patients With Cancer 12/9/2013  More...
Shire plc's New Eye Drug, Lifitegrast, Disappoints In Pivotal Trial 12/6/2013  More...
New Phase 3 Data Backs Promise Of Sanofi (France) (SAN.PA)'s Long-Acting Insulin 12/4/2013  More...
BioAlliance Pharma Release: Approval To Start Relive (Livatag®) Phase III Clinical Trial In Primary Liver Cancer In The US And Germany 12/4/2013  More...
AB Science (AB.PA) Announces Initiation Of A New Phase 3 Study In Oncology With Masitinib In Patients With Metastatic Colorectal Cancer 12/3/2013  More...
Basilea Pharmaceutica (BSLN.SW) Reports That Isavuconazole Receives Qualified Infectious Disease Product (QIDP) Designation From U.S. FDA For The Treatment Of Invasive Aspergillosis 12/3/2013  More...
Swedish Orphan Biovitrum's Partner Biogen Idec, Inc. (Massachusetts) (BIIB) To Present Phase 3 Data On Prolonged Half-Life Of Hemophilia Candidates In Young Children At Annual American Society of Hematology Meeting 12/3/2013  More...
Novo Nordisk A/S (NVO)'s Ryzodeg® Offers Improved Glycemic Control With Significantly Lower Rates Of Hypoglycaemia Compared To Biphasic Insulin Aspart 30 In Adults With Type 2 Diabetes 12/3/2013  More...
Novartis AG (NVS) Chases Pfizer Inc. (PFE) In Hot New Breast Cancer Drug Area 11/25/2013  More...
RedHill Biopharma Ltd. (RDHL) Announces First Patient Dosed In Phase 3 Study Of RHB-104 For Crohn's Disease 11/25/2013  More...
Sanofi (France) (SAN.PA), Regeneron Pharmaceuticals, Inc. (REGN) Arthritis Drug Meets Goals In Phase 3 Study 11/22/2013  More...
Basilea Pharmaceutica (BSLN.SW) Reports Isavuconazole Orphan Drug Designation For Treatment Of Zygomycosis By FDA 11/18/2013  More...
GW Pharmaceuticals Provides Update On Orphan Program In Childhood Epilepsy For Epidiolex® 11/15/2013  More...
GlaxoSmithKline (GSK) Heart Drug Misses Goal In Major Study 11/13/2013  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) and Swedish Orphan Biovitrum Release: Leading Hematology Journal Publishes Pivotal Eloctate Tm Data That Demonstrated Efficacy And Safety Of Investigational Long-Lasting Therapy For Hemophilia A 11/13/2013  More...
AB Science (AB.PA): Final Results Of Phase 3 Mastocytosis Study Expected By End Of 2014 11/12/2013  More...
ALK-Abello A/S's Partner In North America, Merck & Co. (Westpoint, PA) (MRK), Reports Phase III Data On Investigational Grass Sublingual Allergy Immunotherapy Tablet 11/11/2013  More...
AB Science (AB.PA): Masitinib Successfully Passes Futility Analysis in Pivotal Clinical Study in Mastocytosis 11/11/2013  More...
Clinuvel Successful In U.S. Phase III Trial Of SCENESSE® In Rare Skin Disorder 11/11/2013  More...
Pharming Group (PHGUF.PK) and Santarus Inc. (SNTS) Announce New Data From Open-Label Repeat Treatment Study With Rucomest 11/8/2013  More...
Bone Therapeutics' Pivotal Phase III Osteonecrosis Trial With PREOB® hits a New Milestone 11/7/2013  More...
ProSensa Holding N.V. (RNA) Enrolls 100th Patient to its Natural History Study of Duchenne Muscular Dystrophy 11/7/2013  More...
Genentech (RHHBY)'s Gazyva Extends Leukemia Patients’ Survival 11/7/2013  More...
Shire plc's ADHD Drug Succeeds in Phase 3 Trial to Treat Binge Eating 11/5/2013  More...
Medivir AB (MVRBF) Announces That New Simeprevir Data Will be Presented at the American Association for Study of Liver Diseases Meeting 11/4/2013  More...
Auris Medical AG Reaches Special Protocol Assessment Agreement With FDA for Pivotal Phase III Clinical Trial With AM-101 in Treatment of Acute Peripheral Tinnitus 11/4/2013  More...
FDA Clears Commencement of Phase 3 Chronic Heart Failure Trial Using Mesoblast Limited (MSB.AX)'s Proprietary Cells 10/31/2013  More...
RedHill Biopharma Ltd. (RDHL) Initiates Phase III Study of RHB-105 for H. pylori Infection 10/30/2013  More...
Boehringer Ingelheim Corporation Release: New Data show Striverdi® (olodaterol)* Respimat® Improves Exercise Tolerance in Patients With Moderate to Very Severe COPD1 10/29/2013  More...
Roche (RHHBY)'s Investigational Roactemra Subcutaneous Formulation Shows Comparable Long-Term Efficacy and Tolerability to the Intravenous Formulation in Rheumatoid Arthritis 10/28/2013  More...
BioAlliance Pharma Announces Third Positive DSMB Recommendation to Continue Its Phase III Clinical Trial With Livatag® in Primary Liver Cancer 10/22/2013  More...
vasopharm BIOTECH GmbH Reports Endorsement of Phase III Trial Design in Traumatic Brain Injury by European Medicines Agency 10/22/2013  More...
Medivir AB (MVIRb.F) Announces Data From Two Phase 3 Studies With Simeprevir in Hepatitis C Subpopulations – HCV/HIV Co-Infected and Genotype 4 Infected Patients 10/18/2013  More...
Celgene International Sárl (CELG) Release: ABRAXANE® Phase III Study of Patients With Metastatic Pancreatic Cancer Published in The New England Journal of Medicine 10/17/2013  More...
Gilead Sciences, Inc. (GILD)'s Single Tablet HIV Regimen Stribild® Demonstrates Durable Viral Suppression Through Three Years of Therapy 10/16/2013  More...
RedHill Biopharma Ltd. (RDHL)'s RHB-104 Combination Achieves 80% Remission in Independent Pediatric Crohn's Study 10/15/2013  More...
This Slide Paints Grim Picture of GlaxoSmithKline (GSK), ProSensa Holding N.V. (RNA)'s DMD Drug 10/11/2013  More...
Alkermes plc (ALKS) Receives Fast Track Designation for ALKS 5461 for Major Depressive Disorder 10/10/2013  More...
AOP Orphan Pharmaceuticals AG Announces Progress of Pivotal Phase III Trial PROUD-PV of Novel Mono-Pegylated Interferon Alpha 2b for the Treatment of Polycythemia Vera 10/10/2013  More...
Lundbeck Inc. (LUN.CO) and Otsuka Pharmaceutical Co., Ltd. Initiate Phase 3 Clinical Trials on Lu AE58054 as a New Add-on Treatment for Alzheimer's Disease 10/10/2013  More...
Novartis AG (NVS)'s Omalizumab Shines in Third Phase 3 Hives Trial 10/8/2013  More...
RedHill Biopharma Ltd. (RDHL) Reports Positive PK Clinical Studies Towards Planned NDA with RHB-102 (Anti-Emetic) 10/8/2013  More...
Novartis AG (NVS)'s Secukinumab Set to Challenge Amgen (AMGN), Pfizer Inc. (PFE)'S Enbrel® 10/7/2013  More...
Medivir AB (MVIRb.F) Release: Simeprevir Data From COSMOS Study in Hepatitis C Patients Will be Presented as Late-Breaking Presentation at American Association for Study of Liver Diseases 10/7/2013  More...
Celgene International Sárl (CELG) Release: Oral Apremilast Significantly Improved Nail and Scalp Psoriasis and Health-Related Quality-of-Life Measures in Phase III ESTEEM 1 Study 10/3/2013  More...
Roche (RHHBY) Updates Late-Stage Pipeline; Highlights Drugs Outside Core Cancer Focus 10/2/2013  More...
RedHill Biopharma Ltd. (RDHL) Initiates Phase III Study of RHB-104 for Crohn's Disease 10/1/2013  More...
Active Biotech AB (BTPC) and Teva Pharmaceutical Industries Limited (TEVA) Release: Newly Published Phase 3 Exploratory Analysis Suggests Investigational Oral Laquinimod for Multiple Sclerosis May Reduce Brain Damage Caused by Neurodegeneration 10/1/2013  More...
Boehringer Ingelheim Corporation Release: Nintedanib Extended Survival Beyond One Year for Advanced Adenocarcinoma Patients After Prior First-Line Chemotherapy 9/30/2013  More...
Merck Serono's Erbitux Significantly Extends Survival by 7.5 Months in mCRC RAS Wild-Type Patients When Compared With Bevacizumab: New Analysis of FIRE-3 AIO Study 9/30/2013  More...
Ipsen (IPN.PA): Results From CLARINET® Phase3 Clinical Trial Showed the Antiproliferative Effect of Somatuline® in the Treatment of Non-Functioning GEP-NETs 9/30/2013  More...
Astellas Pharma Inc. (ALPMY) Reports Positive Topline Phase 3 Results for Antifungal Isavuconazole 9/30/2013  More...
Sanofi (France) (SAN.PA) Cholesterol Drug Touted as Potential $3 Billion Blockbuster 9/27/2013  More...
Eli Lilly and Company (LLY) Reports Positive Patient-Reported Health Outcomes From Phase 3 Dulaglutide Trial 9/26/2013  More...
Amarin Corporation PLC (AMRN) Announces Enrollment of the REDUCE-IT Cardiovascular Outcomes Study Surpasses 6,000 Patients 9/25/2013  More...
Zealand Pharma  (ZEAL.CO) Informs That Data Presented on Lyxumia® Support Known Complementary Effects of This Diabetes Medicine in Combination With Basal Insulin 9/24/2013  More...
GlaxoSmithKline (GSK), ProSensa Holding N.V. (RNA)'s Muscular Dystrophy Drug Fails in Phase 3 Trial; ProSensa Stock Plunges -70.25% at Market Close on September 20, 2013 9/23/2013  More...
FDA Grants Breakthrough Status for GlaxoSmithKline (GSK), Genmab A/S (GEN.CO)'s Arzerra®; Genmab Stock Soars +9.94% at Market Close (September 16, 2013) 9/17/2013  More...
Ipsen (IPN.PA) Reports Positive Data From Carcinoid Syndrome Phase 3 Drug Trial 9/17/2013  More...
Boehringer Ingelheim Corporation and Eli Lilly and Company (LLY) Present Efficacy and Safety Data on Linagliptin and Investigational Compound Empagliflozin* in Various Diabetes Subpopulations 9/17/2013  More...
Algeta Release: New Data and Analyses From the Phase 3 ALSYMPCA Trial of Xofigo® (Radium Ra 223 Dichloride) Injection to be Presented at the European Cancer Congress (ECCO-ESMO-ESTRO) 2013 9/12/2013  More...
Ironwood Pharmaceuticals and AstraZeneca PLC (AZN) Initiate Linaclotide Phase 3 Trial in China for Adults With IBS-C 9/10/2013  More...
Novartis AG (NVS) Data Presented at ERS Showcases Once-Daily COPD Portfolio and Further Demonstrates Efficacy of Ultibro® Breezhaler® (QVA149) 9/9/2013  More...
Celgene International Sárl (CELG) Reports POMALYST Met Prrimary Endpoint in Phase 3 Trial 9/5/2013  More...
Veloxis Pharmaceuticals A/S (VELO) Release: Phase 3 Clinical Study Data Demonstrating LCP-Tacro™’s Comparable Efficacy and Safety to Twice-Daily Tacrolimus Presented at the European Society for Organ Transplantation 9/4/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) to Drop Depression Treatment After Phase 3 Trial Fails 9/3/2013  More...
Takeda Pharmaceutical Co. Ltd. (TKPYY) EXAMINE Cardiovascular Safety Outcomes Trial of Alogliptin Met Primary Endpoint of Non-Inferiority Compared to Placebo in Addition to Standard of Care Showing No Increase in Cardiovascular Risk in Type 2 Diabetes Patients at High-Risk for Cardiovascular Events 9/3/2013  More...
Daiichi Sankyo, Inc. (4568.t)'s Edoxaban Matched Warfarin in Study 9/3/2013  More...
European Medicines Agency Accepts Proposed Single Pivotal Phase 3 for Second IBD Indication for Alicaforsen Enema for European Marketing Approval 8/29/2013  More...
PharmaEngine, Inc. Announces Achieving Patient Enrollment Goal in the Phase III Metastatic Pancreatic Cancer Study of PEP02 (MM-398) 8/29/2013  More...
Mesoblast Limited's Strong Cash Position Enables Execution of Late-Stage Clinical Trials 8/29/2013  More...
TopoTarget A/S Release: First Patient Dosed in Part One Confirmatory BelCHOP Study in PTCL 8/28/2013  More...
GlaxoSmithKline (GSK)'s Crohn's Disease Drug Fails Phase 3 Trial, ChemoCentryx, Inc. (CCXI) Stock Falls -32.12% on Friday at Market Close (August 23, 2013) 8/26/2013  More...
Sanofi Pasteur (SASY.PA)'s Fluzone Proves Efficient in Trials 8/26/2013  More...
Takeda Pharmaceutical Co. Ltd. (TKPYY) and Zinfandel Pharmaceuticals Inc. Initiate Phase 3 TOMMORROW Trial of AD-4833 for the Delay of Onset of Mild Cognitive Impairment Due to Alzheimer's Disease in Subjects Selected Using a Genetic-Based Biomarker Risk Assignment Algorithm 8/26/2013  More...
RedHill Biopharma Ltd. (RDHL) Announces Positive European Regulatory Meetings Regarding Its European Phase III Plan for RHB-104 (Crohn's) 8/20/2013  More...
Boehringer Ingelheim Corporation and Eli Lilly and Company (LLY) Release: Phase III Safety and Efficacy Data of Trajenta® (linagliptin) in Elderly People With Type 2 Diabetes Published in The Lancet 8/15/2013  More...
Boehringer Ingelheim Corporation Announces Full Patient Enrolment for Two of Its Pivotal Phase III Interferon-Free Hepatitis C Clinical Trials 8/15/2013  More...
Regeneron Pharmaceuticals, Inc. (REGN) and Bayer HealthCare AG (BAY) Report Positive One-Year Results From Two Phase 3 Trials of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema 8/8/2013  More...
The Medicines Company (MDCO) Announces Positive Phase III Trial Results for Fibrocaps; Completes ProFibrix Acquisition 8/6/2013  More...
Sanofi Pasteur (SASY.PA) Initiates Phase 3 Study of Investigational Clostridium Difficile Vaccine in the United States 8/5/2013  More...
Vital Therapies, Inc. (VTI) Receives Orphan Designation in Europe 8/5/2013  More...
Celgene International Sárl (CELG) Release: Study of REVLIMID® (lenalidomide) in Patients with High-Risk Asymptomatic Smoldering Multiple Myeloma Published in The New England Journal of Medicine 8/1/2013  More...
Boehringer Ingelheim Corporation's Afatinib Shows Benefits for EGFR Mutation Positive Non-Small Cell Lung Cancer Patients Across Various Efficacy Endpoints 8/1/2013  More...
BTG plc (BTG.L) Announces Positive Results From VANISH-2 Study Data Published in the Journal Phlebology 7/26/2013  More...
New Roche (RHHBY) Leukemia Drug Tops Rituxan in Study 7/25/2013  More...
Basilea Pharmaceutica (BSLN.SW) Provides Update on Isavuconazole Phase 3 Program 7/17/2013  More...
Dompe Announces Innovative Treatment in the Fight Against Type 1 Diabetes: Pancreatic Islet Cell Transplantation, a Hope That Has Already Come True 7/11/2013  More...
ALK-Abello A/S Release: Positive Results From Pivotal Phase III Trial of New Allergy Immunotherapy Tablet Against House Dust Mite-Induced Allergic Asthma 7/11/2013  More...
Ipsen (IPN.PA)'s Tumor Drug Somatuline Superior to Placebo in Delaying Disease Progression 7/11/2013  More...
Novartis AG (NVS)'s Psoriasis Drug Superior to Amgen (AMGN)'s Enbrel in Study 7/9/2013  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) and Swedish Orphan Biovitrum Present New Data From the Phase 3 Study of Their Long-Lasting Hemophilia Factor Candidate ELOCTATE™ 7/8/2013  More...
Dompe Announces the European Medicines Agency Has Granted Orphan Drug Designation to Its rhNGF-Based Treatment for Retinitis Pigmentosa 7/1/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) Release: Phase III Data Published in Annals of Neurology Show That a Higher Concentration Dose of Glatiramer Acetate Given Three Times a Week Reduced Annualized Relapse Rates in the Treatment of Relapsing-Remitting Multiple Sclerosis 7/1/2013  More...
Novartis (NVS) Heart Drug Gets FDA's "Breakthrough" Status 6/26/2013  More...
New GlaxoSmithKline (GSK) Diabetes Drug Works, But Faces Tough Competition 6/25/2013  More...
Boehringer Ingelheim Corporation and Eli Lilly and Company (LLY) Release: Results of New Meta-Analysis Regarding CV Events in Linagliptin Phase 3 Trials Presented at American Diabetes Association 6/25/2013  More...
Vical Incorporated (VICL) and Astellas Pharma Inc. (YPH.BE) Announce Initiation of Phase 3 Trial of ASP0113 Cytomegalovirus Vaccine 6/25/2013  More...
Novartis AG (NVS) Tests Copy of Amgen (AMGN)'s Enbrel in Late-Stage Trial 6/24/2013  More...
Sanofi (France) (SAN.PA) Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes 6/24/2013  More...
Zealand Pharma Informs of Commercial and Regulatory Status Updates Provided by Sanofi (France) (SAN.PA) on Lyxumia® for Type 2 Diabetes 6/24/2013  More...
Sanofi (France) (SAN.PA) Plans Late-Stage Diabetes Pen Tests in 2014 6/24/2013  More...
ALK-Abello A/S Announces Positive Outcome of Pivotal Phase III Trial With New Allergy Immunotherapy Tablet Against House Dust Mite Allergy 6/19/2013  More...
Ipsen (IPN.PA) Release: "PRIMARYS" Study Investigators Observed Clinically Relevant Results in an Investigational Phase III Study With Somatuline® Autogel® 120 mg in Patients With Acromegaly 6/18/2013  More...
Incyte Corporation (INCY) Drug Jakafi® (ruxolitinib) Improved Overall Survival in Phase III Trial of Patients With Myelofibrosis 6/17/2013  More...
Orexo AB: First Patient Dosed in New Phase III Study Targeted Towards a Future Clinical Indication Expansion for Zubsolv 6/17/2013  More...
Orexo AB Release: First Patient Dosed in New Phase III Study Targeted Towards a Future Clinical Indication Expansion for Zubsolv 6/17/2013  More...
Immunomedics, Inc. (IMMU) Presents Epratuzumab's Mechanism of Action in Systemic Lupus Erythematosus 6/13/2013  More...
Janssen Biotech Inc. Release: Five-Year SIMPONI Data Reported In Treatment of Signs and Symptoms of Moderately to Severely Active Rheumatoid Arthritis 6/12/2013  More...
Celgene International Sárl (CELG) Release: Signs and Symptoms of Psoriatic Arthritis Significantly Improved in Patients Receiving Long-Term Oral Apremilast Treatment in Phase III Study (PALACE-1) 6/12/2013  More...
Ferrer Internacional Successfully Completes a Phase III Clinical Trial in Adult and Paediatric Patients With Impetigo for Novel Antibacterial Compound Ozenoxacin 6/12/2013  More...
Boehringer Ingelheim Corporation's Investigational Faldaprevir+ Achieved Viral Cure in 88% of Treatment-Naive Hepatitis C Patients in Asia 6/10/2013  More...
AstraZeneca PLC (AZN) Scraps Rigel Pharmaceuticals, Inc. (RIGL) Arthritis Pill in New R&D Blow, Astra to Write Off $140 Million Charge 6/6/2013  More...
Medivir AB (MVIRb.F) Release: Primary Efficacy and Safety Data From Four Phase III Japanese Studies of Simeprevir Presented at The Japan Society of Hepatology 6/6/2013  More...
Eisai Company, Ltd. (ESALY.PK) Presents New Quality of Life Findings in Patients with Metastatic Breast Cancer From Halaven® (Eribulin) Versus Capecitabine Study at 49th American Society of Clinical Oncology Annual Meeting 6/3/2013  More...
Boehringer Ingelheim Corporation Release: LUME-Lung 1: Nintedanib* Plus Chemotherapy Extends the Life of Lung Cancer Patients With Adenocarcinoma 6/3/2013  More...
Celgene International Sárl (CELG) Release: Updated Studies Evaluating POMALYST® (pomalidomide) In Previously Treated Multiple Myeloma Patients Presented at American Society of Clinical Oncology 6/3/2013  More...
Celgene International Sárl (CELG) Release: Analyses of MPACT Trial Evaluating ABRAXANE® Combination Therapy for the Treatment of Advanced Pancreatic Cancer Presented at American Society of Clinical Oncology 2013 6/3/2013  More...
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: American Society of Clinical Oncology Presentation Highlights Results of Single Agent oral MLN9708 in Heavily Pretreated Patients with Relapsed and/or Refractory Multiple Myeloma 6/3/2013  More...
GlaxoSmithKline (GSK), Genmab A/S (GEN.CO) Say Combo Boosts PFS in P3 Leukemia Study 5/30/2013  More...
FDA Designates Alexion Pharmaceuticals Inc. (ALXN)'s Product for Rare Disease as "Breakthrough Therapy" 5/30/2013  More...
Amarin Corporation PLC (AMRN) Announces Additional Effects of Vascepa® on Lipoprotein Particle Concentration From the ANCHOR Study Presented at the National Lipid Association 2013 Annual Scientific Sessions 5/30/2013  More...
Beijing Vigoo Biological Says EV71 Vaccine Passes Phase III Test 5/30/2013  More...
NeuroVive Pharmaceutical AB: European Phase III Study Approaches Its Final Stage 5/29/2013  More...
Novo Nordisk A/S (NVO) Says Obesity Drug Trial Confirms Weight Loss 5/28/2013  More...
SALVAT Completes Enrollment of Phase III Study for a New Combination in Acute Otitis Media in Pediatric Patients With Tympanostomy Tubes (AOMT) 5/28/2013  More...
TauRx Therapeutics Release: First UK Patients Enroll in Phase 3 Clinical Trials of LMTX™ for Alzheimer's Disease 5/23/2013  More...
Bayer HealthCare (BAY) Says Lung Drug Shows Promise in Prolonged Trial 5/22/2013  More...
Vectura Group plc (VEC.L) Release: New Data Presented at the American Thoracic Society Meeting Highlights Strength of Once-Daily COPD Portfolio in Improving Lung Function, Shortness of Breath and Reducing Rate of Exacerbations 5/21/2013  More...
Medivir AB (MVIRb.F) Release: Primary Efficacy and Safety Findings From Phase III Study of Simeprevir in Treatment-Experienced Patients Demonstrate Sustained Virologic Response 5/21/2013  More...
Sanofi (France) (SAN.PA) Plans to File JAK2 Inhibitor After Positive Phase III 5/20/2013  More...
Genentech (RHHBY) Cancer Antibody, Son of Rituxan, Nails Pivotal Study 5/20/2013  More...
AB Science (AB.PA): Launch of a Phase 3 Clinical Trial in Alzheimer's Disease 5/20/2013  More...
Lundbeck Inc. (LUN.CO) Release: Vortioxetine Clinical Phase III Data Show Significant Improvement in Symptoms of Major Depression 5/20/2013  More...
Veloxis Pharmaceuticals A/S (VELO) Release: Final STRATO Clinical Study Data Demonstrates Potential for LCP-TacroTM to Improve Tacrolimus-Induced Tremors 5/20/2013  More...
AstraZeneca PLC (AZN) Advances Three Cancer Drugs Into Late-Stage Trials 5/17/2013  More...
Novo Nordisk A/S (NVO) Reports Positive Results From First Phase 3 Trial With Long-Acting Factor IX for Treatment of Hemophilia B 5/17/2013  More...
Roche (RHHBY) Banks on New Drug Data to Defend Cancer Business 5/16/2013  More...





 

//-->